ArticleAnnals of Ibadan postgraduate medicine2013
Dyspepsia management in a resource poor setting.
Article in Annals of Ibadan postgraduate medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDyspepsia has a significant impact on the quality of life of the sufferer, and results in enormous societal costs, either due to direct medical costs for physician visits, diagnostic tests, medications, or indirect costs from absenteeism or reduced productivity at work. It is therefore important to explore the management options available, especially in a resource poor setting like Nigeria, in the light of the foregoing.
methodsExtensive internet literature search was made through Google scholar, Pubmed and HINARI. Keywords employed were dyspepsia, prevalence and management.
resultSEVERAL APPROACHES PROPOSED FOR THE MANAGEMENT OF A NEWLY DIAGNOSED PATIENT WITH DYSPEPSIA INCLUDE: empirical trial of acid suppression for 4-8 weeks in regions with low prevalence of H. pylori; the "test and treat" approach for H. pylori infection using a validated non-invasive test and; initial use of upper gastrointestinal endoscopy to determine the nature of the disease before treatment in patients with alarm symptoms and those who are more than 45 years. Helicobacter pylori eradication therapy without initial diagnostic testing can be used as the last result in resource poor regions of the word where diagnostic tests for H. pylori are not available or not cost-effective.
conclusionConsidering the high cost of upper gastrointestinal endoscopy and the high prevalence of H. pylori infection in developing countries like Nigeria, it seems reasonable that the 'test and treat' method will be of immense usefulness in population sub-group who are less than 45 years without alarm symptoms, while those with alarm symptoms and those with onset of symptoms after 45 years will require initial upper gastrointestinal endoscopy.
Indexed as
Identifiers
25161415PMC4111057What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.